发明名称 Copolymers for suppression of autoimmune diseases, and methods of use
摘要 Random three- and four-amino acid copolymers having lengths of 14-, 35- and 50-amino acid residues are provided. Fifty-mers of FEAK were effective inhibitors of MBP 85-99- or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell clones. These copolymers efficiently suppressed the mouse disease EAE, which was induced in a susceptible SJL/J (H-2s) strain of mice with either whole spinal cord homogenate (WSCH) or with the encephalitogenic epitope PLP 139-151 (SEQ ID NO:4). YFAK 50-mer having a molar ratio of about Y 0.8:F 0.2 inhibited binding of biotinylated MBP 85-99 epitope to HLA-DR-2 molecules more efficiently than either unlabeled MBP 85-99 or Copaxone®. YFAK and FAK copolymers efficiently suppressed EAE induced in SJL/J (H-2S) mice with the encephalitogenic epitope PLP 139-151. Copolymers YFAK, VYAK and tryptophan-containing VWAK were efficacious in alleviating severity and duration of symptoms of EAE induced by MBP 85-99 (SEQ ID NO:2), in a humanized mouse model expressing genes for both an HLA-DR-2 linked to multiple sclerosis (MS) in humans and for a T cell receptor from an MS patient.
申请公布号 US8017125(B2) 申请公布日期 2011.09.13
申请号 US20070005239 申请日期 2007.12.26
申请人 PRESIDENT AND FELLOWS OF HARVARD COLLEGE 发明人 STROMINGER JACK L.;FRIDKIS-HARELI MASHA
分类号 A61K39/00;A61K45/00;A61K38/00;A61K38/20;A61K38/21;A61K38/55;A61P3/10;A61P5/14;A61P7/04;A61P17/06;A61P21/04;A61P25/00;A61P29/00;A61P31/04;A61P37/02;A61P43/00;C07K14/00 主分类号 A61K39/00
代理机构 代理人
主权项
地址